Atlas Trials

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Clinical trial NCT03278275 · COMPLETED

Trial details

NCT number
NCT03278275
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2017-11-01
Primary completion
2021-07-08
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.